Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Astaxanthin Market to Reach $1.6 Billion, Globally, by 2033 at 8.1% CAGR: Allied Market Research

This image opens in the lightbox

News provided by

Allied Market Research

18 Feb, 2026, 16:16 GMT

Share this article

Share toX

Share this article

Share toX

Rising prevalence of chronic diseases, increasing demand for natural antioxidants in nutraceuticals and cosmetics, and rapid advancements in microalgae cultivation technologies are the major factors which drive the global astaxanthin market growth.

WILMINGTON, Del., Feb. 18, 2026 /PRNewswire/ -- Allied Market Research published a report, titled, "Astaxanthin Market by Source (Natural and Synthetic), Form (Dry and Liquid), and Application (Dietary supplements, Cosmetics and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the astaxanthin market was valued at $0.8 billion in 2023, and is estimated to reach $1.6 billion by 2033, growing at a CAGR of 8.1% from 2024 to 2033.

Request Sample of the Report on Astaxanthin Market Forecast 2033 -
https://www.alliedmarketresearch.com/request-sample/A324369 

Prime Determinants of Growth

The increasing prevalence of chronic diseases and lifestyle-related disorders, rising consumer preference for natural antioxidants in dietary supplements and functional foods, and expanding applications in cosmetics and animal feed are the major factors that drive the growth of the astaxanthin market. In addition, growing awareness regarding preventive healthcare and rising demand for clean-label and plant-based products contribute significantly to market expansion. However, the high production cost associated with natural astaxanthin extraction and complex cultivation processes restrains market growth. Moreover, technological advancements in microalgae cultivation and sustainable production methods offer remunerative opportunities for the expansion of the global astaxanthin market.

Report Coverage & Details 

Report Coverage   

Details   

Forecast Period   

2024–2033  

Base Year   

2023

Market Size in 2023   

$0.8 billion  

Market Size in 2033  

 $3.2 billion

CAGR   

7.8 %

No. of Pages in Report   

280

Segments Covered   

Source, Form, Application, and Region 

Drivers  

  

•         Increasing demand for natural antioxidants

•         Growing application in nutraceuticals and cosmetics

•         Rising awareness regarding preventive healthcare

Opportunity   

•         Advancements in sustainable microalgae production technologies 

Restraint   

•         High production cost of natural astaxanthin 

Want to Explore More, Connect to our Analyst -
https://www.alliedmarketresearch.com/connect-to-analyst/A324369 

In clinical nutrition and biomedical research, astaxanthin is used to study the prevention and management of chronic conditions such as cardiovascular diseases, diabetes, inflammation, and skin disorders. Advanced extraction and microencapsulation technologies enhance its bioavailability and stability, enabling researchers and manufacturers to develop targeted nutraceutical formulations. These insights support preventive healthcare strategies and improve long-term wellness outcomes.

The astaxanthin market also extends beyond dietary supplements into cosmetics, functional foods, and animal nutrition. Innovations in natural sourcing from microalgae and sustainable production methods enhance product purity, efficacy, and environmental compatibility. These advancements improve consumer confidence, promote clean-label solutions, and strengthen global health and wellness applications.  

Segment Highlights

The natural segment dominated the market share in 2023

By source, the natural segment dominated the market share in 2023. This is attributed to the growing consumer preference for naturally derived ingredients sourced primarily from microalgae such as Haematococcus pluvialis. Natural astaxanthin is widely recognized for its superior antioxidant potency and safety profile compared to synthetic alternatives, making it highly desirable in nutraceuticals, cosmetics, and functional foods. Increasing demand for clean-label, plant-based, and non-GMO products further accelerates the adoption of natural astaxanthin.

The dry segment accounted for the largest market share in 2023

By form, the dry segment dominated the market share in 2023. This is attributed to its higher stability, longer shelf life, and ease of incorporation into capsules, tablets, and powdered formulations. Dry astaxanthin is widely used in dietary supplements and functional food applications due to its convenience in storage, transportation, and dosage standardization. Manufacturers prefer dry formulations as they offer improved handling and compatibility with various delivery systems. In addition, advancements in microencapsulation technologies enhance bioavailability and protect the compound from oxidation, thereby driving segment growth. Increasing demand for supplement products in capsule and tablet forms further supports the dominance of the dry segment.

The dietary supplements segment dominated the market share in 2023

By application, the dietary supplements segment accounted for the largest market share in 2023. This is attributed to the rising prevalence of lifestyle-related disorders and growing consumer focus on preventive healthcare. Astaxanthin is extensively used in supplements for its antioxidant, anti-inflammatory, and immune-supporting properties. The increasing aging population and growing awareness regarding cardiovascular health, skin health, and eye health significantly contribute to higher demand. Moreover, expanding distribution channels, including e-commerce platforms and specialty health stores, further fuel segment expansion.

Asia-Pacific to maintain its dominance by 2033

Region wise, Asia-Pacific held the largest market share in 2023 and is expected to maintain its dominance during the forecast period. This is attributed to strong production capabilities of microalgae, rising health awareness, and growing demand for nutraceuticals and cosmetics in countries such as China, Japan, and India. Increasing investments in biotechnology and expanding middle-class population with higher disposable income further support regional growth.

For Purchase Related Queries/Enquiry -
https://www.alliedmarketresearch.com/purchase-enquiry/A324369 

Key Players  

  • INNOBIO Limited 
  • Divis Laboratories Limited 
  • Algaecan Biotech 
  • ALGA Technologies,  
  • Cyanotech Corporation 
  • Otsuka Pharmaceutical Co. 
  • Cardax, Fenchem 
  • BGG  
  • Fuji Chemical Industries Company Limited 
  • Kunming Biogenic Company Limited

Why Is Demand Increasing in the Astaxanthin Market?

There is an increase in the demand for astaxanthin due to the rising prevalence of chronic diseases, growing awareness regarding preventive healthcare, and increasing consumer preference for natural antioxidants. The shift toward wellness-oriented lifestyles significantly fosters market growth. Individuals are increasingly opting for dietary supplements and functional foods containing astaxanthin to support cardiovascular health, skin vitality, eye health, and immune function.

The surge in demand for natural and clean-label products also boosts market expansion. Consumers are actively seeking plant-based and sustainably sourced ingredients, particularly those derived from microalgae. This trend is further supported by expanding e-commerce platforms and rising disposable incomes in developing economies. The growing aging population worldwide contributes substantially to market growth, as older adults seek antioxidant-rich supplements to combat oxidative stress and age-related health concerns.

Technological advancements in microalgae cultivation and extraction processes further accelerate demand. Innovations such as closed-loop cultivation systems and enhanced extraction techniques improve product purity, stability, and bioavailability. Additionally, expanding applications in cosmetics, animal nutrition, and functional beverages, along with increasing investments in biotechnology and sustainable production infrastructure, continue to strengthen global demand for astaxanthin-based products.

Recent Development  

  • In December 2023, AX3 Life, a human longevity company, announced breakthrough life extension findings related to its longevity supplement, AX3 Bio-Pure Astaxanthin, a highly bioavailable, pure, and environmentally sustainable form of astaxanthin that safely fights inflammation and other hallmarks of aging to improve lifespan and health span.
  • In 2024, Divis Laboratories Limited launched the AstaBead high‑stability astaxanthin beadlet formulation to boost product stability and ease of use in supplements and functional foods. The company also earmarked significant investments toward expanding purification capacity in India by 2025 to meet rising demand.

The report provides a detailed analysis of these key players in the global astaxanthin market. These players have adopted different strategies such as expansion, product launch, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Explore AMR's Extensive Ongoing Coverage on Life Science Industry: 

Microbiome Sequencing Market - https://www.alliedmarketresearch.com/microbiome-sequencing-market-A13576 

Lymphoma Therapeutics Market - https://www.alliedmarketresearch.com/lymphoma-therapeutics-market 

Ultrasound Devices Market - https://www.alliedmarketresearch.com/Ultrasound-Devices-market 

Immunoglobulin Market - https://www.alliedmarketresearch.com/immunoglobulin-market

Drug Discovery Outsourcing Market - https://www.alliedmarketresearch.com/drug-discovery-outsourcing-market-A14914 

Organoids and Spheroids Market - https://www.alliedmarketresearch.com/organoids-and-spheroids-market-A17036 

Therapeutic Drug Monitoring Market - https://www.alliedmarketresearch.com/therapeutic-drug-monitoring-market-A09152 

AVENUE - A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library on Avenue, designed specifically to offer cost-effective, one-stop solutions for enterprises, investors, and universities. With Avenue, subscribers can avail themselves of an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Us

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.

Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
To find out more, visit www. Alliedmarketresearch.com or follow us on Twitter, LinkedIn and Facebook.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Modal title

Also from this source

Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research

Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Biocompatible Coating Market by Type (Antimicrobial, Hydrophilic and Others), Material (Polymer,...

Advance Directives Market Poised to Surge to $510.2 Billion by 2033 at a 15.4% CAGR: Allied Market Research

Advance Directives Market Poised to Surge to $510.2 Billion by 2033 at a 15.4% CAGR: Allied Market Research

The advance directives market growth is fueled by rise in investments in advance care planning, increase in global geriatric population, and surge in ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

Supplementary Medicine

Supplementary Medicine

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.